3 ms·
Very good point @bilbo0s and thank you for bringing this up. I didn't mention it as we focused on a non-clinical diagnostic (thus not subject to FDA), decided
by TuringNYC 10y ago
Very good point @bilbo0s and thank you for bringing this up. I didn't mention it as we focused on a non-clinical diagnostic (thus not subject to FDA), decided to entirely avoid the US market (focus on more less risk averse economies open to innovation and aligned via ACO-style systems.)
FDA is definitely the biggest hurdle of them all. I'd shudder if we had to deal with that 600 pound gorilla.